Learn more

MIZ CO LTD

Overview
  • Total Patents
    189
  • GoodIP Patent Rank
    29,728
  • Filing trend
    ⇩ 36.0%
About

MIZ CO LTD has a total of 189 patent applications. It decreased the IP activity by 36.0%. Its first patent ever was published in 1992. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets environmental technology, pharmaceuticals and materials and metallurgy are MIZU KK, AKUATECH S R L and SPRING CO LTD.

Patent filings per year

Chart showing MIZ CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Satoh Bunpei 92
#2 Satoh Fumitake 86
#3 Seo Tomoki 73
#4 Kurokawa Ryosuke 51
#5 Arai Kazuyoshi 46
#6 Kurokawa Ryousuke 46
#7 Yanagihara Tomoyuki 36
#8 Sato Fumitake 21
#9 Miyamae Kazuhiro 17
#10 Sato Bunpei 17

Latest patents

Publication Filing date Title
JP2020164507A Composition for improving renal function of renal disease containing molecular hydrogen
WO2020141800A1 Method, server, and program for measuring body size and recommending clothing size by using image
WO2020141751A1 Method for obtaining picture for measuring body size and body size measurement method, server, and program using same
KR20200084780A Method, server and program of measuring body size using images and recommend clothing size
JP2020079227A Composition for improvement or prevention of symptoms of parkinson's disease
JP2020200268A Composition for improving symptom of spine/spinal cord injury
JP2020045330A Hydrogen-containing composition
JP2019116519A Composition for preventing or inhibiting bacterial translocation
JP2019116518A Composition for preventing or improving abnormality in bacterial strain composition of intestinal bacterial flora
JP2020176070A Composition for improving aftereffect after stroke
JP2020045329A Composition comprising hydrogen gas for suppression or prevention of cancer metastasis
JP2020037519A Hydrogen-containing composition for improving depressive symptom
JP2020023461A Therapeutic or preventive agent for cardiometabolic disease
JP2020015687A Composition for treating schizophrenia
JP2018172423A Agent for inhibiting deterioration of recognition function, comprising hydrogen gas
JP2020002090A Composition for suppressing or alleviating cancer pain, containing hydrogen
JP2019210237A Age-related macular degeneration therapeutic composition containing hydrogen
KR20190088791A Apparatus for measuring size of part of body and system therefor
JP2019108295A Composition for preventing or inhibiting bacterial translocation
JP2019108294A Composition for preventing or improving abnormality in bacterial strain composition of intestinal bacterial flora